Clinical experience with treatment of melioidosis in children

Pediatric Infectious Disease Journal

Volumn 23, Issue 12, 2004, Pages 1165-1166

  Lumbiganon, Pagakrong ^a   Chotechuangnirun, Napaporn ^b   Kosalaraksa, Pope ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Department of Pediatrics   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; TETRACYCLINE;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; KIDNEY ABSCESS; LIVER ABSCESS; LONG TERM CARE; MALE; MELIOIDOSIS; NONHUMAN; PAROTITIS; PNEUMONIA; PRIORITY JOURNAL; RECURRENCE RISK; SEPTIC SHOCK; SEPTICEMIA; SKIN INFECTION; SPLEEN ABSCESS; TREATMENT OUTCOME; BACTEREMIA; INFANT; PRESCHOOL CHILD;

ADOLESCENT; BACTEREMIA; CEFTAZIDIME; CHILD; CHILD, PRESCHOOL; DOXYCYCLINE; FEMALE; HUMANS; INFANT; MALE; MELIOIDOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 16644401035     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000145477.29311.71     Document Type: Article

References (10)

1. Leelarasamee A. Recent development in melioidosis. Curr Opin Infect Dis. 2004;17:131-136.
2. Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattaraarechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis. 1993;168:1181-1185.
3. White NJ, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 1989;2:697-701.
4. Sookpranee M, Boonma P, Susaengrat W, Bhuripanyo K, Punyagupta S. Multicenter prospective randomized trial comparing ceftazidime plus trimethoprim-sulfamethoxazole with chloramphenicol plus doxycycline and cotrimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother. 1992;36:158-162.
5. Rajchanuwong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DAB, White NJ. Prospective comparison of coamoxiclav and the combination of chloramphenicol, doxycycline, and cotrimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg. 1995;89:546-549.
6. Chaowagul W, Simpson AJH, Suputtamongkol Y, Smith MD, Angus BJ, White NJ. Comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis. 1999;29:375-380.
7. Lumbiganon P, Viengnondha S. Clinical manifestations of melioidosis in children. Pediatr Infect Dis J. 1995;14:136-140.
8. Lumbiganon P, Tattawasatra U, Chetchotisakd P, Wongratanacheewin S, Thinkhamrop B. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. J Med Assoc Thai. 2000;83:856-860.
9. Suputtamongkol Y, Hall AJ, Dance DAB, et al. Epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol. 1994;23:1082-1090.
10. Sirisanthana T, Tharavichitkul P, Preuksakom S. Benign bacteremic melioidosis. In: Punyagupta S, Sirisanthana T, Stapatayavong B, eds. Melioidosis: Proceedings of National Workshop on Melioidosis. Bangkok, Thailand: Bangkok Medical Publisher; 1989:74-79.